Antagonists of interleukin-15
    8.
    发明授权
    Antagonists of interleukin-15 失效
    白细胞介素15的拮抗剂

    公开(公告)号:US07235240B2

    公开(公告)日:2007-06-26

    申请号:US11221399

    申请日:2005-09-07

    IPC分类号: A61K39/00 A61K39/38 A01N37/18

    摘要: Antagonists of mammalian interleukin-15 (“IL-15”) are disclosed and include muteins of IL-15 and modified IL-15 molecules that are each capable of binding to the IL-15Rα-subunit and that are incapable of transducing a signal through either the β- or γ-subunits of the IL-15 receptor complex. Also included are monoclonal antibodies against IL-15 that prevent IL-15 from effecting signal transduction through either the β- or γ-subunits of the IL-15 receptor complex. Methods of treating various disease states are disclosed, including treating allograft rejection and graft-versus-host disease,

    摘要翻译: 公开了哺乳动物白细胞介素-15(“IL-15”)的拮抗剂,并且包括IL-15和修饰的IL-15分子的突变蛋白,其各自能够结合IL-15Rα-亚基并且不能通过 IL-15受体复合物的β亚基或γ亚基。 还包括针对IL-15的单克隆抗体,其阻止IL-15通过IL-15受体复合物的β亚基或γ亚基进行信号转导。 公开了治疗各种疾病状态的方法,包括治疗同种异体移植排斥和移植物抗宿主病,

    Antagonists of interleukin-15
    9.
    发明授权
    Antagonists of interleukin-15 有权
    白细胞介素15的拮抗剂

    公开(公告)号:US06177079B1

    公开(公告)日:2001-01-23

    申请号:US09196427

    申请日:1998-11-20

    IPC分类号: A61K39395

    摘要: Antagonists of mammalian interleukin-15 (“IL-15”) are disclosed and include muteins of IL-15 and modified IL-15 molecules that are each capable of binding to the IL-15R&agr;-subunit and that are incapable of transducing a signal through either the &bgr;- or &ggr;-subunits of the IL-15 receptor complex. Also included are monoclonal antibodies against IL-15 that prevent IL-15 from effecting signal transduction through either the B- or &ggr;subunits of the IL-15 receptor complex. Methods of treating various disease states are disclosed. including treating allograft rejection and graft-versus-host disease.

    摘要翻译: 公开了哺乳动物白细胞介素-15(“IL-15”)的拮抗剂,并且包括IL-15和修饰的IL-15分子的突变蛋白,其各自能够结合IL-15Rα-亚基并且不能通过 IL-15受体复合物的β亚基或γ亚基。 还包括针对IL-15的单克隆抗体,其阻止IL-15通过IL-15受体复合物的B-或gammasubunits进行信号转导。 公开了治疗各种疾病状态的方法。 包括治疗同种异体移植排斥和移植物抗宿主病。